ALDH7A1 and COVID-19: This article reviews pharmacological properties of nonselective and selective PDE inhibitors, their mechanisms of action, side effects, and therapeutical potential for the acutely injured lung, summarizes results from the use of PDE inhibitors in the experimental and clinical studies, and estimates possible perspectives of a wider use of PDE inhibitors for an acute lung damage including coronavirus disease 2019 (COVID-19).